| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K04800985 | CTRPv2 | pan-cancer | AAC | 0.01 | 0.8 |
| mRNA | tandutinib | CTRPv2 | pan-cancer | AAC | 0.01 | 0.8 |
| mRNA | SGX-523 | CTRPv2 | pan-cancer | AAC | 0.01 | 0.8 |
| mRNA | Carboplatin | CTRPv2 | pan-cancer | AAC | 0.0099 | 0.8 |
| mRNA | BRD-K02251932 | CTRPv2 | pan-cancer | AAC | 0.01 | 0.8 |
| mRNA | TAE684 | CTRPv2 | pan-cancer | AAC | -0.009 | 0.8 |
| mRNA | BRD-K85133207 | CTRPv2 | pan-cancer | AAC | 0.0094 | 0.8 |
| mRNA | BRD-K71935468 | CTRPv2 | pan-cancer | AAC | -0.0096 | 0.8 |
| mRNA | alisertib:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0086 | 0.8 |
| mRNA | semagacestat | CTRPv2 | pan-cancer | AAC | 0.009 | 0.8 |